
Empirical antibiotic treatment with piperacillin-tazobactam in patients with microbiologically-documented biliary tract infections
Author(s) -
Gabrio Bassotti,
Fabio Chistolini,
Francis Sietchiping-Nzepa,
Giuseppe De-Roberto,
Antonio Morelli
Publication year - 2004
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v10.i15.2281
Subject(s) - piperacillin/tazobactam , medicine , tazobactam , piperacillin , empiric therapy , antibiotics , biliary tract , antimicrobial , intensive care medicine , gastroenterology , microbiology and biotechnology , antibiotic resistance , pathology , biology , bacteria , pseudomonas aeruginosa , genetics , imipenem , alternative medicine
To report our experience with empiric antimicrobial monotherapy (piperacillin/tazobactam, of which no data are available in such specific circumstances) in microbiologically-documented infections in patients with benign and malignant conditions of the biliary tract.